SIGA Technologies Experiences Significant Options Trading Activity

On December 26, 2024, SIGA Technologies, Inc. (NASDAQ:SIGA) made headlines due to an unusual surge in options trading activity. On this particular Wednesday, traders purchased 1,200 call options for the company, marking a staggering increase of approximately 1,438% compared to the usual daily volume of just 78 call options.

Current Stock Performance of SIGA Technologies

As of Thursday's opening, shares of SIGA Technologies were priced at $6.00. The company has a fifty-day simple moving average of $6.71, alongside a 200-day simple moving average of $7.69. With a market capitalization of $428.43 million, SIGA Technologies is currently trading at a price-to-earnings (P/E) ratio of 5.00, and its beta stands at 0.89. Over the past year, the stock has experienced a low of $4.26 and a high of $12.83.

Recent Earnings Report

SIGA Technologies reported its latest earnings results on November 7. The company announced earnings per share (EPS) of $0.02 for the reported quarter. Additionally, SIGA Technologies reported a net margin of 49.33% and a return on equity of 49.06%. The revenue for the quarter was recorded at $10.01 million. Analysts predict that SIGA Technologies will achieve an EPS of 1.04 for the current financial year.

Institutional Holdings in SIGA Technologies

Recent activity from large investors indicates increased interest in SIGA Technologies. For instance, AltraVue Capital LLC raised its position in the company by 6.6% during the second quarter, now holding 2,177,646 shares valued at around $16.53 million after acquiring an additional 134,450 shares. Hotchkis & Wiley Capital Management LLC significantly boosted its stake by 152.6% in the third quarter, acquiring 1,237,620 shares, which now totals 2,048,440 shares worth approximately $13.83 million. Furthermore, Dimensional Fund Advisors LP increased its holdings by 7.9%, while Geode Capital Management LLC and American Century Companies Inc. have also enhanced their positions. In total, institutional investors and hedge funds collectively own 55.40% of SIGA Technologies’ stock.

Overview of SIGA Technologies

SIGA Technologies, Inc. is a pharmaceutical company focused on health security markets within the United States. The company’s lead product, TPOXX, is an antiviral oral formulation designed for treating human smallpox caused by the variola virus. Founded in 1995, SIGA Technologies is headquartered in New York, New York.

SIGA, Trading, Options